🔎 Trials Near Me

Hjem › Multipelt myelom › Delaware

Multipelt myelom kliniske forsøg i Delaware

4 studier for Multipelt myelom søger deltagere på steder i Delaware.

Byer i Delaware

Officiel studietekst (engelsk)

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

  • ChristianaCare Helen F Graham Cancer Center and Research Institute, Newark
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT05552222

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

  • Medical Oncology Hematology Consultants /ID# 268560, Newark
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT05650632

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

  • Christiana Care, Newark
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 4. jun. 2026 · NCT05243797

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

  • Medical Oncology Hematology Consultants, Newark
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 22. apr. 2026 · NCT05972135

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.